Alphabet Bulls Undeterred By Biggest Antitrust Case in Decades
Google Antitrust Trial Isn't Hurting Alphabet Stock, Outshines Apple - Bloomberg
Antitrust Anxiety Part 2 - Capital Advisors Group
2022 Year in Review: White & Case Global Antitrust Merger StatPak (WAMS) | White & Case LLP
The Antitrust Attorney Blog — Published by California Antitrust Lawyer — Jarod Bona of Bona Law PC.
Major federal 'Big Tech' antitrust case against Google will test the strength of current U.S. antitrust laws in new digital markets - Equitable Growth
The ongoing big tech antitrust cases to watch in 2023
Google loses appeal against record $4 billion EU fine | CNN Business
Disney Hit With Antitrust Lawsuit Over Streaming TV Prices – The Hollywood Reporter
New Law Library of Congress Report Examines Pharmaceutical Antitrust Cases | In Custodia Legis
Antitrust M&A Snapshot | Q2 2022 Print Edition
Antitrust M&A Snapshot | Q2 2022 Print Edition
DAMITT 2022 Annual Report: Timing and Remedy Risks Grow for Transactions Hit with Significant Investigations | Dechert LLP
Jenner & Block | “The Antitrust Conduct Cases To Watch In 2022,” <i>Law360</i> | Jenner & Block LLP
Antitrust Anxiety Part 2 - Capital Advisors Group
Publishing antitrust case showcases Biden's stance on antitrust enforcement - Marketplace
Attorney General Josh Stein Supports Continuation of Antitrust Case Against HCA - NCDOJ
The state of U.S. federal antitrust enforcement - Equitable Growth
Khan's First Year as FTC Chair: More Antitrust Lawsuits, But Fewer Overall Actions | by Ife Ogunleye | Chamber of Progress | Medium
At Mid-year, US Merger Filings Down From 2021's Torrid Pace, But Still Far Above the Historic Average | White & Case LLP
DOJ's antitrust case against Google is ambitious but risky
Antitrust Merger Enforcement Update and Outlook - Gibson Dunn
DOJ Asks Court to Limit Scope of MLB's Antitrust Exemption - The New York Times
European Union moves forward in antitrust case against Apple | AP News
The growing demand for more vigorous antitrust action
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics | Reuters
Interim Measures in Antitrust Investigations- Marcela Mattiuzzo- June 2022 OECD Discussion | PPT
